Pelvic Floor Muscle Training: Pelvic floor muscle training 5x/week for 12-weeks
Study summary
The goal of this trial is to learn about the feasibility and benefits of delivering a pelvic floor muscle training program to people with motor-incomplete spinal cord injury. The main questions it aims to answer are:
1. To evaluate the feasibility of delivering a pelvic floor muscle training program to people with spinal cord injury. The investigators will examine recruitment rate, compliance and adherence to the intervention and other study protocols, adverse events, and participant perspectives of the study protocols.
2. To explore the potential effectiveness of pelvic floor muscle training on pelvic floor, bladder, bowel, and sexual function.
Participants will be asked to complete a pelvic floor muscle training program for 3 months. At the beginning, middle, and end of the program, researchers will conduct a series of tests to determine the feasibility and potential effectiveness of this program.
Eligibility
Sex
ALL
Min age
19 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Are at least 19 years of age.
* Have a non-progressive, motor-incomplete spinal cord injury that is at or above the T12 neurological level at least 12 months ago.
* Have symptoms of bladder, bowel, and/or sexual dysfunction that are caused by your spinal cord injury.
* Have stable management of spinal cord related secondary health concerns (e.g., spasticity, neuropathic pain).
* Are able to speak and understand English.
Exclusion Criteria:
* Are currently pregnant, have been pregnant within the past 6 months, or are planning to become pregnant in the next 6 months.
* Have had urogenital surgery within the past 12 months.
* Have received Botox bladder injections within the past 4 weeks, or anticipate receiving an injection in the next 6 months.
* Have presence of severe medical issue that in the investigator's judgement would adversely affect the participant's participation in the study. Examples include, but are not limited to pressure sores, cardiovascular disease, and unmanaged diabetes.
* Have any permanent metal fixtures in their head (excluding dental fillings), or pacemakers, stimulators, or implanted medication pumps.
* Have a history of seizures, are taking medications that lower the seizure threshold, or experience recurring headaches.
* Have a condition for which exercise is contraindicated.
Primary outcome measure(s)
Feasibility - Recruitment Rate — Through study completion, up to 12 weeks Recruitment rate will be evaluated by number of participants approached, screened for eligibility, as well as reasons for exclusions.
Feasibility - Compliance — Through study completion, up to 12 weeks Compliance will be tracked by the adherence of participants to the prescribed exercise program, with reasons for missed sessions or drop-outs noted.
Feasibility - Adverse Events — Through study completion, up to 12 weeks Any adverse events to study protocols will be recorded.
Feasibility - Acceptability — Through study completion, up to 12 weeks The acceptability of the intervention will be evaluated using a 7-point Likert scale to rate participants' enjoyment of the exercise program and whether they felt the program was beneficial for improving their bladder, bowel, and/or sexual function.
Trial sites (1)
Facility
City
Region
Status
Blusson Spinal Cord Centre
Vancouver
British Columbia
Recruiting
More University of British Columbia trials in Canada
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.